Analysis of Incentive Policies and Initiatives on Orphan Drug Development in China: Challenges, Reforms and Implications

OBJECTIVES: Rare diseases are a global public health issue with a more pressing situation in China. Unfortunately, the relevant research and development in this country are still in its infancy, leading to limited drug accessibility. In view of this, the Chinese government has taken a series of coun...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhiyao, Pei, Zhongyang, Hu, Anxia, Zhang, Yuhui, Chen, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375655/
https://www.ncbi.nlm.nih.gov/pubmed/37501126
http://dx.doi.org/10.1186/s13023-023-02684-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375655/
https://www.ncbi.nlm.nih.gov/pubmed/37501126
http://dx.doi.org/10.1186/s13023-023-02684-8

Ejemplares similares